Rossari Biotech Limited / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €205.11M +13.6% €13.45M +4.4% 6.6% -0.0058 pp €29.18M +69.6% 14.2% +0.047 pp
    €180.49M +10.5% €12.89M +21.8% 7.1% +0.0066 pp €17.21M -5.8% 9.5% -0.017 pp
    €163.26M +12.2% €10.58M +9.8% 6.5% -0.0014 pp €18.27M +174.1% 11.2% +0.066 pp
    €145.45M +108.5% €9.63M +21.8% 6.6% -0.047 pp €6.66M -36.2% 4.6% -0.10 pp
    €69.75M +18.3% €7.91M +22.9% 11.3% +0.0043 pp €10.44M -19.1% 15.0% -0.069 pp
    €58.98M +16.6% €6.43M +42.8% 10.9% +0.020 pp €12.90M +13.6% 21.9% -0.0058 pp
    €50.59M +76.1% €4.50M +79.8% 8.9% +0.0019 pp €11.36M +191.6% 22.4% +0.089 pp
    €28.73M +24.1% €2.50M +77.8% 8.7% +0.026 pp €3.89M +358.9% 13.6% +0.099 pp
    €23.16M €1.41M 6.1% €848.62K 3.7%

    Notifications